These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9735086

  • 1. Management of pituitary tumors.
    Shimon I, Melmed S.
    Ann Intern Med; 1998 Sep 15; 129(6):472-83. PubMed ID: 9735086
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec 15; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and Treatment of Pituitary Adenomas: A Review.
    Molitch ME.
    JAMA; 2017 Feb 07; 317(5):516-524. PubMed ID: 28170483
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of pituitary adenomas].
    Mezosi E, Nemes O.
    Orv Hetil; 2009 Sep 27; 150(39):1803-10. PubMed ID: 19758960
    [Abstract] [Full Text] [Related]

  • 5. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
    Kienitz T, Quinkler M, Strasburger CJ, Ventz M.
    Eur J Endocrinol; 2007 Jul 27; 157(1):39-46. PubMed ID: 17609400
    [Abstract] [Full Text] [Related]

  • 6. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A.
    Eur J Endocrinol; 2003 Apr 27; 148(4):433-42. PubMed ID: 12656664
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec 27; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 8. Effects of medical therapy on pituitary tumors.
    Kovacs K, Horvath E.
    Ultrastruct Pathol; 2005 Dec 27; 29(3-4):163-7. PubMed ID: 16036872
    [Abstract] [Full Text] [Related]

  • 9. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
    Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, Williamson C.
    Obstet Gynecol; 2017 Jan 27; 129(1):185-194. PubMed ID: 27926659
    [Abstract] [Full Text] [Related]

  • 10. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P, Díez JJ.
    J Endocrinol Invest; 1998 Dec 27; 21(11):775-8. PubMed ID: 9972679
    [Abstract] [Full Text] [Related]

  • 11. Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone.
    Leese G, Jeffreys R, Vora J.
    Postgrad Med J; 1997 Aug 27; 73(862):507-8. PubMed ID: 9307745
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec 27; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 13. [Novel pharmacologic therapies in acromegaly].
    Góth M, Hubina E, Kovács L, Szabolcs I.
    Orv Hetil; 2002 May 12; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [Abstract] [Full Text] [Related]

  • 14. Medical management of growth hormone-secreting pituitary adenomas.
    Racine MS, Barkan AL.
    Pituitary; 2002 May 12; 5(2):67-76. PubMed ID: 12675503
    [Abstract] [Full Text] [Related]

  • 15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M, Jacobs RA, Aylwin SJ, Burrin JM, Dahia PL, Monson JP, Honegger J, Fahlbush R, Trainer PJ, Chew SL, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1998 Oct 12; 83(10):3624-30. PubMed ID: 9768675
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.
    Sanno N, Teramoto A, Osamura RY.
    J Neurooncol; 2001 Sep 12; 54(2):179-86. PubMed ID: 11761434
    [Abstract] [Full Text] [Related]

  • 17. [Pituitary adenomas--where is the treatment heading at the beginning of the 21st century?].
    Marek J.
    Vnitr Lek; 2010 Jul 12; 56(7):690-4. PubMed ID: 20842914
    [Abstract] [Full Text] [Related]

  • 18. Dopamine agonists and pituitary tumor shrinkage.
    Bevan JS, Webster J, Burke CW, Scanlon MF.
    Endocr Rev; 1992 May 12; 13(2):220-40. PubMed ID: 1352243
    [Abstract] [Full Text] [Related]

  • 19. New medical approaches in pituitary adenomas.
    Colao A, Di Sarno A, Marzullo P, Di Somma C, Cerbone G, Landi ML, Faggiano A, Merola B, Lombardi G.
    Horm Res; 2000 May 12; 53 Suppl 3():76-87. PubMed ID: 10971110
    [Abstract] [Full Text] [Related]

  • 20. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours.
    Colao A, Filippella M, Pivonello R, Di Somma C, Faggiano A, Lombardi G.
    Eur J Endocrinol; 2007 Apr 12; 156 Suppl 1():S57-S63. PubMed ID: 17413190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.